PAPER Dodge JC, Yu J, Sardi SP, Shihabuddin LS
SEARCH RESULTS
18969 RESULTS
PAPER Talebi M, Talebi M, Kakouri E, Farkhondeh T, Pourbagher-Shahri AM, Tarantilis PA, Samarghandian S
Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases.
Int J Biol Macromol. 2021 Mar 1;172:93-103. Epub 2021 Jan 10 PubMed: 33440210PAPER
Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
Ann Clin Transl Neurol. 2021 Feb;8(2):529. Epub 2021 Jan 13 PubMed: 33440069PAPER Smith R, Strandberg O, Mattsson-Carlgren N, Leuzy A, Palmqvist S, Pontecorvo MJ, Devous MD, Ossenkoppele R, Hansson O
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Brain. 2020 Dec 1;143(12):3805-3815. PubMed: 33439987PAPER Tauffenberger A, Magistretti PJ
Reactive Oxygen Species: Beyond Their Reactive Behavior.
Neurochem Res. 2021 Jan;46(1):77-87. Epub 2021 Jan 13 PubMed: 33439432PAPER Innok W, Hiranrat A, Chana N, Rungrotmongkol T, Kongsune P
In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
J Comput Aided Mol Des. 2021 Mar;35(3):325-336. Epub 2021 Jan 13 PubMed: 33439402PAPER Wu J, Shao C, Ye X, Di X, Li D, Zhao H, Zhang B, Chen G, Liu HK, Qian Y
InVivo Brain Imaging of Amyloid-β Aggregates in Alzheimer's Disease with a Near-Infrared Fluorescent Probe.
ACS Sens. 2021 Mar 26;6(3):863-870. Epub 2021 Jan 13 PubMed: 33438997PAPER Kakinen A, Javed I, Davis TP, Ke PC
In vitro and in vivo models for anti-amyloidosis nanomedicines.
Nanoscale Horiz. 2021 Feb 1;6(2):95-119. Epub 2021 Jan 13 PubMed: 33438715PAPER Raghavan SS, Iqbal S, Ayyadurai N, Gunasekaran K
Insights in the structural understanding of amyloidogenicity and mutation-led conformational dynamics of amyloid beta (Aβ) through molecular dynamics simulations and principal component analysis.
J Biomol Struct Dyn. 2021 Jan 13;:1-11. PubMed: 33438527PAPER
Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
Brain. 2021 May 7;144(4):e42. PubMed: 33437996PAPER Carbone E, Gardini S, Pastore M, Piras F, Vincenzi M, Borella E
Cognitive Stimulation Therapy (CST) for older adults with mild-to-moderate dementia in Italy: effects on cognitive functioning and on emotional and neuropsychiatric symptoms.
J Gerontol B Psychol Sci Soc Sci. 2021 Jan 13; PubMed: 33437991PAPER Sanabria-Diaz G, Melie-Garcia L, Draganski B, Demonet JF, Kherif F
Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment.
Sci Rep. 2021 Jan 12;11(1):845. PubMed: 33436948PAPER Park JC, Jang SY, Lee D, Lee J, Kang U, Chang H, Kim HJ, Han SH, Seo J, Choi M, Lee DY, Byun MS, Yi D, Cho KH, Mook-Jung I
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids.
Nat Commun. 2021 Jan 12;12(1):280. PubMed: 33436582PAPER Yu Q, Mai Y, Ruan Y, Luo Y, Zhao L, Fang W, Cao Z, Li Y, Liao W, Xiao S, Mok VC, Shi L, Liu J, National Alzheimer’s Coordinating Center, the Alzheimer’s Disease Neuroimaging Initiative, Frontotemporal Lobar Degeneration Neuroimaging Initiative
An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease.
Alzheimers Res Ther. 2021 Jan 12;13(1):23. PubMed: 33436059PAPER Moon S, Kim S, Mankhong S, Choi SH, Vandijck M, Kostanjevecki V, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Kim HJ, Jang JW, Hong JY, Park DH, Shaw LM, Kang JH
Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans: CSF AD biomarkers measured by Lumipulse in Koreans.
Alzheimers Res Ther. 2021 Jan 12;13(1):22. PubMed: 33436035Current Filters
- Date Range : Jan 2020 to Jan 2021 x